| Consensus classification of posterior cortical atrophy SJ Crutch, JM Schott, GD Rabinovici, M Murray, JS Snowden, ... Alzheimer's & Dementia 13 (8), 870-884, 2017 | 590 | 2017 |
| Cascading network failure across the Alzheimer’s disease spectrum DT Jones, DS Knopman, JL Gunter, J Graff-Radford, P Vemuri, BF Boeve, ... Brain 139 (2), 547-562, 2016 | 532 | 2016 |
| New insights into atypical Alzheimer's disease in the era of biomarkers J Graff-Radford, KXX Yong, LG Apostolova, FH Bouwman, M Carrillo, ... The Lancet Neurology 20 (3), 222-234, 2021 | 464 | 2021 |
| Longitudinal tau PET in ageing and Alzheimer’s disease CR Jack Jr, HJ Wiste, CG Schwarz, VJ Lowe, ML Senjem, P Vemuri, ... Brain 141 (5), 1517-1528, 2018 | 433 | 2018 |
| Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia VJ Lowe, HJ Wiste, ML Senjem, SD Weigand, TM Therneau, BF Boeve, ... Brain 141 (1), 271-287, 2018 | 313 | 2018 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 297 | 2020 |
| Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging–Alzheimer’s Association research framework CR Jack, TM Therneau, SD Weigand, HJ Wiste, DS Knopman, P Vemuri, ... JAMA neurology 76 (10), 1174-1183, 2019 | 278 | 2019 |
| Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia CR Jack, HJ Wiste, TM Therneau, SD Weigand, DS Knopman, MM Mielke, ... Jama 321 (23), 2316-2325, 2019 | 278 | 2019 |
| Performance of plasma phosphorylated tau 181 and 217 in the community MM Mielke, JL Dage, RD Frank, A Algeciras-Schimnich, DS Knopman, ... Nature medicine 28 (7), 1398-1405, 2022 | 276 | 2022 |
| Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum DT Jones, J Graff-Radford, VJ Lowe, HJ Wiste, JL Gunter, ML Senjem, ... Cortex 97, 143-159, 2017 | 219 | 2017 |
| Age, vascular health, and Alzheimer disease biomarkers in an elderly sample P Vemuri, TG Lesnick, SA Przybelski, DS Knopman, VJ Lowe, ... Annals of neurology 82 (5), 706-718, 2017 | 207 | 2017 |
| AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies K Kantarci, VJ Lowe, BF Boeve, ML Senjem, N Tosakulwong, TG Lesnick, ... Annals of neurology 81 (1), 58-67, 2017 | 199 | 2017 |
| White matter hyperintensities: relationship to amyloid and tau burden J Graff-Radford, EM Arenaza-Urquijo, DS Knopman, CG Schwarz, ... Brain 142 (8), 2483-2491, 2019 | 198 | 2019 |
| Dementia with Lewy bodies: basis of cingulate island sign J Graff-Radford, ME Murray, VJ Lowe, BF Boeve, TJ Ferman, ... Neurology 83 (9), 801-809, 2014 | 188 | 2014 |
| The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes CR Jack Jr, HJ Wiste, H Botha, SD Weigand, TM Therneau, DS Knopman, ... Brain 142 (10), 3230-3242, 2019 | 176 | 2019 |
| Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study DS Knopman, ME Griswold, ST Lirette, RF Gottesman, K Kantarci, ... Stroke 46 (2), 433-440, 2015 | 176 | 2015 |
| Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes MM Mielke, RD Frank, JL Dage, A Jeromin, NJ Ashton, K Blennow, ... JAMA neurology 78 (9), 1108-1117, 2021 | 174 | 2021 |
| Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies Z Nedelska, TJ Ferman, BF Boeve, SA Przybelski, TG Lesnick, ME Murray, ... Neurobiology of aging 36 (1), 452-461, 2015 | 174 | 2015 |
| Executive dysfunction and the prefrontal cortex DT Jones, J Graff-Radford CONTINUUM: Lifelong Learning in Neurology 27 (6), 1586-1601, 2021 | 173 | 2021 |
| Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities JA Syrjanen, MR Campbell, A Algeciras‐Schimnich, P Vemuri, ... Alzheimer's & Dementia 18 (6), 1128-1140, 2022 | 159 | 2022 |
Prashanthi VemuriMayo ClinicPotvrđena adresa e-pošte na mayo.edu